1. Home
  2. NAOV vs CNSP Comparison

NAOV vs CNSP Comparison

Compare NAOV & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAOV
  • CNSP
  • Stock Information
  • Founded
  • NAOV 2003
  • CNSP 2017
  • Country
  • NAOV United States
  • CNSP United States
  • Employees
  • NAOV N/A
  • CNSP N/A
  • Industry
  • NAOV Industrial Specialties
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAOV Health Care
  • CNSP Health Care
  • Exchange
  • NAOV Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • NAOV 5.4M
  • CNSP 5.6M
  • IPO Year
  • NAOV N/A
  • CNSP 2019
  • Fundamental
  • Price
  • NAOV $5.15
  • CNSP $1.09
  • Analyst Decision
  • NAOV
  • CNSP Hold
  • Analyst Count
  • NAOV 0
  • CNSP 1
  • Target Price
  • NAOV N/A
  • CNSP N/A
  • AVG Volume (30 Days)
  • NAOV 4.9M
  • CNSP 212.0K
  • Earning Date
  • NAOV 05-14-2025
  • CNSP 05-14-2025
  • Dividend Yield
  • NAOV N/A
  • CNSP N/A
  • EPS Growth
  • NAOV N/A
  • CNSP N/A
  • EPS
  • NAOV N/A
  • CNSP N/A
  • Revenue
  • NAOV $2,558,000.00
  • CNSP N/A
  • Revenue This Year
  • NAOV N/A
  • CNSP N/A
  • Revenue Next Year
  • NAOV N/A
  • CNSP N/A
  • P/E Ratio
  • NAOV N/A
  • CNSP N/A
  • Revenue Growth
  • NAOV 12.05
  • CNSP N/A
  • 52 Week Low
  • NAOV $1.92
  • CNSP $0.77
  • 52 Week High
  • NAOV $16.25
  • CNSP $800.00
  • Technical
  • Relative Strength Index (RSI)
  • NAOV 48.45
  • CNSP 38.32
  • Support Level
  • NAOV $5.86
  • CNSP $0.83
  • Resistance Level
  • NAOV $6.24
  • CNSP $1.14
  • Average True Range (ATR)
  • NAOV 1.58
  • CNSP 0.15
  • MACD
  • NAOV -0.10
  • CNSP 0.08
  • Stochastic Oscillator
  • NAOV 20.77
  • CNSP 53.18

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: